Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
NPJ Vaccines|July 21, 2024
A trivalent protein-based pan-Betacoronavirus vaccine elicits cross-neutralizing antibodies against a panel of coronavirus pseudovirusesSyamala Rani Thimmiraju, Rakesh Adhikari, JeAnna R Redd, et al.
Scientific Reports|January 16, 2024
Novel species of Triatoma (Hemiptera: Reduviidae) identified in a case of vectorial transmission of Chagas disease in northern BelizeSarah M Gunter, Alisa Nelson, Alexander R Kneubehl, et al.
Infectious Disease Reports|June 26, 2024
Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Healthcare Personnel in El Salvador Prior to Vaccination CampaignsJosé Elías Aguilar Ramírez, Adrianna Maliga, Allison Stewart, et al.
The American Journal of Tropical Medicine and Hygiene|February 9, 2026
Infectious Causes of Acute Febrile Illness in Belize, 2020-2022Adrianna Maliga, Shannon E Ronca, Russell Manzanero, et al.
Expert Review of Vaccines|May 30, 2023
From concept to delivery: a yeast-expressed recombinant protein-based COVID-19 vaccine technology suitable for global accessPeter J Hotez, Rakesh Adhikari, Wen-Hsiang Chen, et al.
Iscience|December 4, 2023
Early cellular and molecular signatures correlate with severity of West Nile virus infectionHo-Joon Lee, Yujiao Zhao, Ira Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 24, 2021
DNA-encoded chemistry technology yields expedient access to SARS-CoV-2 Mpro inhibitorsSrinivas Chamakuri, Shuo Lu, Melek Nihan Ucisik, et al.
Vaccine|October 13, 2021
Development of an IgG-Fc fusion COVID-19 subunit vaccine, AKS-452David G Alleva, Andrea R Delpero, Melanie M Scully, et al.
Vaccine|February 4, 2022
Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19 subunit vaccine, AKS-452Yester F Janssen, Eline A Feitsma, Hendrikus H Boersma, et al.
NPJ Vaccines|February 21, 2024
Immunogenicity phase II study evaluating booster capacity of nonadjuvanted AKS-452 SARS-Cov-2 RBD Fc vaccineDavid G Alleva, Eline A Feitsma, Yester F Janssen, et al.
Pageof 5